Back to Journals

Vascular Health and Risk Management

Professor Asmar

Foundation - Medical Research Institutes, F-MRI, France

Professor Asmar

Editor-in-Chief: Professor Roland Asmar

Professor Asmar is Chairman of the Foundation - Medical Research Institutes (France) and past-President of the French spoken network on hypertension. Prior to this position, he was Associate Professor of Therapy and past-president of the Working Group ‘Measurement and Evaluation’ of the French Society of Hypertension. Professor Asmar is a member of several prestigious international committees and scientific societies.

He received the distinction ‘Cardiologist of the Year 2001’ in France in recognition of his long and continuing contributions to medical education.


Professor Asmar has published over 300 scientific articles and several books in the area of cardiology.

Professor Asmar’s research interests include blood pressure measurements, non-invasive evaluation of arterial status and atherosclerosis, cardiovascular clinical intervention trials, and development of new cardiovascular methods and drug agents.

Professor Cameron

Monash Cardiovascular Research Centre, Australia

Professor Cameron

Associate Editor (Australia): Professor James D. Cameron

Professor Cameron holds Professorships at both La Trobe University (Biomedical Engineering) and Monash University (adjunct in Medicine) and a senior medical staff appointment at Monash Medical Centre where he is Associate Director of MonashHEART and Director of the Monash Cardiovascular Research Centre. He is internationally known for work on large, conduit artery function and mechanics, their influence on mechanisms of disease and their role in risk-assessment and the identification of pre-clinical states. His work provided some of the first evidence that arterial function is modifiable and therefore a therapeutic target. Particular interests are in hypertension, assessment of arterial function in vascular health and biological ageing. He was co-recipient of the 2004 RJ Hall prize of the Cardiac Society of Australia and New Zealand and was admitted to Fellowship of the Society in 2006.

Dr Duprez

Cardiovascular Division, University of Minnesota, United States

Dr Duprez

Associate Editor (United States): Professor Daniel Duprez

Professor Duprez is Professor of Medicine, holder of the Donald and Patricia Garofalo Chair for Preventive Cardiology, Director of Research of the Rasmussen Center for Cardiovascular Disease Prevention at the Medical School and Adjunct Professor in Epidemiology and Community Health at the School of Public Health at the University of Minnesota. Professor Duprez is Fellow of the American Heart Association, Fellow of the American College of Cardiology, Fellow of the European Society of Cardiology, Fellow of the American Society of Hypertension and Fellow of the National Lipid Association. His research focus is to improve early detection of cardiovascular disease, leading to new effective therapeutic approaches. He has several research grants regarding arterial stiffness in health and disease.

Dr Kajiya

Cardiology, Tenyoukai Central Hospital, Japan

Dr Kajiya

Associate Editor (Japan): Doctor Takashi Kajiya 

Doctor Kajiya is a Senior Consultant Cardiologist at Tenyoukai Central Hospital, Japan. He obtained his medical degree at the Kagoshima University, Japan in 2001 and did a postdoctoral fellowship at the University of California San Francisco (2009-2011) and an interventional cardiology fellowship at the National University Heart Centre in Singapore (2011-2013). Dr Kajiya is Fellow of the American College of Cardiology, Fellow of the European Society of Cardiology, and Fellow of the Asian Pacific Society of Interventional Cardiology. His research focus is to improve outcomes of coronary intervention.

Dr Scicchitano

Cardiology, University of Bari, Italy

Dr Scicchitano

Associate Editor (Italy): Doctor Pietro Scicchitano 

Doctor Scicchitano is a Medical Doctor at the University of Bari, Italy. He completed his degree in Medicine and Surgery in 2008, discussing a thesis entitled “Evaluation of cardiovascular risk in patients suffering from Polycystic Ovary Syndrome”.

Doctor Scicchitano has authored over 80 peer-reviewed scientific articles, 110 abstracts published and three chapters in scientific books.

Dr Struijker-Boudier

Dr Struijker-Boudier

Associate Editor: Professor Doctor Harry Struijker-Boudier

Professor Doctor Struijker-Boudier is emeritus Professor of Pharmacology at Maastricht University, The Netherlands.

Professor Doctor Struijker-Boudier graduated in 1973 in Pharmacochemistry and Biochemistry and obtained his Ph.D. in Pharmacology in 1975 from the Radboud University Nijmegen, The Netherlands. He was appointed Professor of Experimental Pharmacology at Maastricht University in 1980 and Chairman of the Department of Pharmacology and Toxicology in 1984. From 1999 to 2006 he served as scientific director of the Cardiovascular Research Institute Maastricht (CARIM).

Harry Struijker-Boudier has published more than 500 scientific papers in peer-reviewed international journals and books in the areas of cardiovascular pharmacology, hypertension, heart failure and drug design and delivery. He was Vice President of the scientific council of the European Society of Hypertension and board member of the European Federation of Pharmacological Societies. He is doctor honoris causa of the University of Liège, Belgium, recipient of the Descartes-Huygens prize of the French Government, member of the Dutch Royal Society of Sciences and Officer of the Order of Oranje-Nassau of the Dutch Royal House.

Dr Tziomalos

Department of Internal Medicine, Aristotle University of Thessaloniki, Greece

Dr Tziomalos

Associate Editor (Greece): Doctor Konstantinos Tziomalos 

Konstantinos Tziomalos is Assistant Professor of Internal Medicine at the First Propedeutic Department of Internal Medicine of the Medical School, Aristotle University of Thessaloniki, in AHEPA Hospital, Thessaloniki, Greece. He completed his residency at the Second Propedeutic Department of Internal Medicine of the Medical School, Aristotle University of Thessaloniki, in Hippokration Hospital, Thessaloniki, Greece. He then served as a clinical research fellow at the Department of Clinical Biochemistry (Vascular Prevention Clinic), Royal Free Campus, University College London Medical School, University College London, UK and as a post-doctorate research fellow at the Stem Cell Institute and Cardiovascular Research Laboratory, Division of Cardiology, Miller School of Medicine, University of Miami, USA. His research interests include dyslipidemia, stroke and cardiovascular disease prevention. He has authored more than 300 peer-reviewed scientific articles, which have received more than 6000 citations.

Dr Wang

Department of Cardiology and Vascular Medicine, Peking University Shougang Hospital, China Mainland (PRC)

Dr Wang

Associate Editor (South East Asia): Doctor Hongyu Wang

Doctor Wang is a Chief Physician in the Department of Cardiology and Vascular Medicine and Professor at the Peking University Shougang Hospital, Republic of China. 

Doctor Wang graduated at Shanxi Medical School in 1990. His research interests focus on early detection of vascular disease and vascular disease therapy. Doctor Wang is the recipient of numerous Awards. He is on the Executive Board of the International Society of Vascular Health and he is a member of the American Society of Hypertension.


Editorial Board

Christina Antza, 3rd Department of Internal Medicine, Aristotle University, Hypertention-24h ABPM Center, Thessaloniki, Greece

Pitchai Balakumar, Associate Professor of Pharmacology and Head of the Pharmacology Unit, Faculty of Pharmacy, AIMST University, Malaysia

Christie M Ballantyne, Professor, Baylor College of Medicine, Houston, USA

Maciej Banach, Professor, MD, PhD, President, Polish Mother’s Memorial Hospital Research Institute (PMMHRI), Poland.

Ravinay Bhindi, Department of Cardiology, University of Sydney Royal North Shore Hospital, Sydney, Australia

Eric Bruckert, Professor, Service d'endocrinologie-métabolisme, Paris, France

Doctor Patrick C. Brunel, MD, MSc in pharmacology, cardiologist, University René Descartes, Paris, France.

Peter W de Leeuw, Department of Medicine, University Hospital Maastricht, Maastricht, The Netherlands

Francesco Fantin, Associate Professor, Department of Medicine, University of Verona, Italy.

Jan Filipovsky, Head of the Department of Internal Medicine, Charles University, Pilsen, Czech Republic

Luis Garcia Ortiz, MD, Salamanca Primary Care Research Unit (APISAL), Instituto de Investigación Biomédica de Salamanca (IBSAL), Spain.

Armen Gasparyan, MD, PhD, Clinical Research Unit, Dudley Group of Hospitals NHS Trust, West Midlands, UK

Joseph Izzo, Professor of Medicine and Pharmacology, State University of New York, Buffalo, USA

Bojan Jelaković, Associate Professor of Internal Medicine, University of Zagreb. Director of the Center for Hypertension and Head of the Department of Nephrology, University Hospital Center Zagreb, Croatia

Amudha Kadirvelu, Associate Professor, Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia

Gregory YH Lip, Price-Evans Professor of Cardiovascular Medicine, Liverpool Centre for Cardiovascular Science, Institute of Ageing and Chronic Disease, University of Liverpool, UK;
National Institute for Health Research (NIHR) Senior Investigator;
Distinguished Professor, Faculty of Medicine, Aalborg University, Denmark;
Adjunct Professor, Yonsei University, Seoul, South Korea

Iveta Mintale, Latvian Centre of Cardiology, Pauls Stradiņ Clinical University Hospital, Riga, Latvia; Research Institute of Cardiology, University of Latvia, Riga, Latvia.

Sir Salvador Moncada, FRS, FRCP, FMedSci, Cancer Domain, University of Manchester, UK

Vasilios Papademetriou, Professor of Medicine, Center for Hypertension, Kidney & Vascular Research, VA Medical Center, Georgetown University Medical Center, Washington, DC, USA

Nalini Rajamanna, Department of Cardiovascular Medicine, Mayo Clinic, Rochester, USA.

Ibrahim Sari, Department of Cardiology, School of Medicine, Marmara University, Istanbul, Turkey

Rahul Sheth MD, Assistant Professor, Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Kohji Shirai, Emeritus professor of Medical School, Toho University.

Donald R. J. Singer, Professor, President, Fellowship of Postgraduate Medicine, London, UK

Yuriy Sirenko, Professor, Department of Symptomatic Hypertension, Institute of Cardiology, Ukraine.

Reza Tabrizchi, Professor of Pharmacology (Cardiovascular), Associate Dean, Research & Graduate Studies, Memorial University of Newfoundland, Canada

Nebojsa Tasic, Professor of Internal Medicine, Medical Faculty, University of Belgrade, Assistant Director for Cardiovascular research, Cardiovascular Institute, Head of Center for Cardiovascular Research, Cardiovascular Institute "Dedinje", Belgrade, Serbia.

Larry A. Weinrauch, Mount Auburn Hospital, Harvard Medical School, Cambridge, MA, USA

Nanette Wenger, Professor, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA

Paronak Zelveian, Professor, Director of Institute of Cardiology, Yerevan, Armenia.

Chunyu Zeng, Dean, Hospital of Cardiology; Chairman, Department of Cardiology; Professor of Cardiology; Chairman, Chongqing Institute of Cardiology; Department of Cardiology, Daping Hospital, The Third Military Medical University, People's Republic of China

Yi Zhang, MD, PHD, FACC, FESC, Interventional Cardiologist, Department of Cardiology, Shanghai Tenth People's  Hospital, Tongji University School of Medicine. Shanghai, China.